Multiple studies indicated that a pro-inflammatory state is a component of T2D with dyslipidemia and a correlation between high Interleukin 6 (IL-6) levels and subjects with type 2 diabetes and dyslipidemia risk factors has been observed [26]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.